Heerspink HJ, Cherney D, Postmus D, Stefansson BV, et al. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function. Kidney Int 2021 Sep 21. pii: S0085-2538(21)00865.
PMID: 34560136